

ReNeuron Group
RENE:LNLondon Stock Exchange (AIM)
Overview
Company Profile
We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
Classification
SectorHealthcare
ExchangeLondon Stock Exchange (AIM)
BoardAIM
